Skip Navigation


NDT Advance Access originally published online on November 7, 2006
Nephrology Dialysis Transplantation 2007 22(3):819-826; doi:10.1093/ndt/gfl636
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/3/819    most recent
gfl636v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Toprak, O.
Right arrow Articles by Esi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toprak, O.
Right arrow Articles by Esi, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease

Omer Toprak1, Mustafa Cirit1, Murat Yesil2, Serdar Bayata2, Mehmet Tanrisev1, Umut Varol3, Rifki Ersoy1 and Ertap Esi4

1Department of Nephrology, 2Department of First Cardiology, 3Department of Second Internal Medicine and 4Department of Radiology, Ataturk Training and Research Hospital, Izmir, Turkey

Correspondence and offprint requests to: Omer Toprak, MD, Ataturk Training and Research Hospital, Department of Nephrology, 35360 Izmir, Turkey. Email: info{at}omertoprak.com



  Abstract

Background. The aim of the present study was to assess the influence of diabetic and pre-diabetic state on the development of contrast-induced nephropathy (CIN) in chronic kidney disease patients undergoing coronary angiography.

Methods. A total of 421 patients with Cockcroft clearance between 15 and 60 ml/min were divided into three groups [diabetes mellitus (DM), n = 137; pre-diabetes (pre-DM), n = 140; and normal fasting glucose (NFG), n = 144]. CIN was defined as an increase of ≥25% in creatinine over baseline within 48 h of angiography, DM as glucose ≥126 mg/dl, pre-DM as glucose between 100 and 125 mg/dl and NFG as glucose <100 mg/dl.

Results. CIN occurred in 20% of the DM [relative risk (RR) 3.6, P = 0.001], 11.4% of the pre-DM (RR 2.1, P = 0.314) and 5.5% of the NFG group. The decrease of glomerular filtration rate (GFR) was higher in DM and pre-DM (P = 0.001 and P = 0.002, respectively). GFR ≤30 ml/min (RR 19.22), multivessel involvement (RR 7.59), hyperuricaemia (RR 3.95), use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker (RR 2.70) and DM (RR 2.34) were predictors of CIN. Length of hospital stay was 2.45 ± 1.45 day in DM, 2.27 ± 0.68 day in pre-DM and 1.97 ± 0.45 day in NFG (P < 0.001, DM vs NFG and P = 0.032, pre-DM vs NFG). The rate of major adverse cardiac events was 8.7% in DM, 5% in pre-DM and 2.1% in NFG (P = 0.042, DM vs NFG). Haemodialysis was required in 3.6% of DM and 0.7% in pre-DM (P = 0.036, DM vs NFG), and the total number of haemodialysis sessions during 3 months was higher in DM and pre-DM (P < 0.001). Serum glucose ≥124 mg/dl was the best cut-off point for prediction of CIN.

Conclusion. Our data support that patients with DM are at a higher risk of developing CIN, but patients with pre-DM are not at as high a risk for developing CIN as diabetes patients.

Keywords: contrast-induced nephropathy; coronary angiography; diabetes mellitus; pre-diabetes; renal insufficiency

Received for publication: 20. 8.06
Accepted in revised form: 3.10.06


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
F. Ferrario, M. T. Barone, G. Landoni, A. Genderini, M. Heidemperger, M. Trezzi, E. Piccaluga, P. Danna, and D. Scorza
Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study
Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3103 - 3107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Kuhn, N. Chen, D. V. Sahani, D. Reimer, E. J. R. van Beek, J. P. Heiken, and G. J. So
The PREDICT Study: A Randomized Double-Blind Comparison of Contrast-Induced Nephropathy After Low- or Isoosmolar Contrast Agent Exposure
Am. J. Roentgenol., July 1, 2008; 191(1): 151 - 157.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Toprak, M. Cirit, M. Tanrisev, C. Yazici, O. Canoz, M. Sipahioglu, A. Uzum, R. Ersoy, and E. Y. Sozmen
Preventive effect of nebivolol on contrast-induced nephropathy in rats
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 853 - 859.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.